1262412-64-5 Usage
General Description
3,3-Difluoro-5-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester is a chemical compound with the molecular formula C11H18F2N2O3. It is a tertiary butyl ester derivative of 3,3-Difluoro-5-hydroxymethyl-piperidine-1-carboxylic acid, which is a piperidine derivative. 3,3-Difluoro-5-hydroxymethyl-piperidine-1-carboxylic acid tert-butyl ester is commonly used in pharmaceutical research and drug development due to its potential biological activity and pharmacological properties. Its unique structure and functional groups make it an interesting target for the synthesis of new drug candidates, particularly in the field of neurological and psychiatric disorders. Additionally, it may also have applications in organic synthesis and as a building block for the preparation of other complex chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1262412-64-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,2,4,1 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1262412-64:
(9*1)+(8*2)+(7*6)+(6*2)+(5*4)+(4*1)+(3*2)+(2*6)+(1*4)=125
125 % 10 = 5
So 1262412-64-5 is a valid CAS Registry Number.
1262412-64-5Relevant articles and documents
DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0168; 0171, (2019/07/18)
The present invention relates to a dihydropyrimidine compound having an antiviral activity, a pharmaceutical composition comprising same, a preparation method therefor and the uses thereof in the prevention or treatment of viral diseases including, but no
SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 0392, (2015/02/19)
Compounds having the formula I wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, Rd, Re, n, r, s and t are as defined herein and which compounds are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.
SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 0183; 0184, (2014/11/11)
Compounds having the formula I, or a pharmaceutically acceptable salt thereof, wherein R1, R2, X1, X2, and Ar are as defined herein, are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.